The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000138.5(FBN1):c.7577A>G (p.Asn2526Ser)

CA017256

200198 (ClinVar)

Gene: FBN1
Condition: Marfan syndrome
Inheritance Mode: Autosomal dominant inheritance
UUID: f57714a2-598c-4e48-a07e-6858c037050e
Approved on: 2023-06-15
Published on: 2023-06-15

HGVS expressions

NM_000138.5:c.7577A>G
NM_000138.5(FBN1):c.7577A>G (p.Asn2526Ser)
NC_000015.10:g.48421680T>C
CM000677.2:g.48421680T>C
NC_000015.9:g.48713877T>C
CM000677.1:g.48713877T>C
NC_000015.8:g.46501169T>C
NG_008805.2:g.229109A>G
ENST00000682170.1:n.1758A>G
ENST00000682767.1:n.874A>G
ENST00000316623.10:c.7577A>G
ENST00000674301.1:n.2743A>G
ENST00000316623.9:c.7577A>G
ENST00000559133.5:n.2946A>G
NM_000138.4:c.7577A>G
More

Likely Pathogenic

Met criteria codes 4
PS4 PP3 PP2 PM2_Supporting
Not Met criteria codes 21
PVS1 PS2 PS3 PS1 BA1 PP1 PP4 PM3 PM4 PM5 PM1 PM6 BS4 BS3 BS1 BS2 BP7 BP5 BP2 BP3 BP4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen FBN1 Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 1

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
FBN1 VCEP
The NM_000138 c.7577A>G variant is a missense variant in FBN1 predicted to cause a substitution of asparagine by serine at position 2526. This variant has been identified in the literature and public and private databases in one proband with a clinical diagnosis of Marfan syndrome and in seven probands with thoracic aortic aneurysm and dissection (TAAD) and/or other features suggestive of Marfan syndrome (PS4; PMID: 17657824, Invitae and GeneDx internal data, ClinVar ID: 200198, UZA internal data). This variant lies in a critical calcium binding site within a calcium-binding EGF domain; however, since asparagine to serine substitutions in these positions might be tolerated (PMID: 31227806) the PM1 criterion has not been used. This variant is not present in gnomAD v2.1.1 or v3.1.2 (PM2_supporting; https://gnomad.broadinstitute.org/). Computational prediction tools and conservation analysis suggest that this variant may impact the protein structure (PP3; REVEL = 0.821). The constraint z-score for missense variants affecting FBN1 is 5.06 (PP2). In summary, this variant meets criteria to be classified as likely pathogenic for Marfan syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen FBN1 VCEP: PS4, PM2_supporting, PP2, PP3).
Met criteria codes
PS4
> 4.0 PS4 points
PP3
REVEL = 0.821
PP2
missense variant, no benign criteria applied
PM2_Supporting
absent from gnomAD v2.1.1 and 3.1.2
Not Met criteria codes
PVS1
n/a
PS2
no evidence
PS3
no evidence
PS1
n/a
BA1
PM2_supporting met
PP1
no evidence
PP4
internal proband does not meet revised Ghent criteria
PM3
n/a for FBN1
PM4
n/a
PM5
n/a
PM1
consensus calcium-binding sequence in cbEGF40; Asparagine>Serine might be tolerated
PM6
no evidence
BS4
no evidence
BS3
no evidence
BS1
PM2_supporting met
BS2
no evidence
BP7
n/a
BP5
no evidence
BP2
no evidence
BP3
n/a for FBN1
BP4
PP3 met
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.